FDA.reportPublic FDA data

treprostinil Oral Tablet Month 2 Titration Kit

RxCUI
2630668
RxNorm name
treprostinil Oral Tablet Month 2 Titration Kit
Display name
treprostinil Oral Tablet Month 2 Titration Kit
Full name
treprostinil Oral Tablet Month 2 Titration Kit
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OrenitramTREPROSTINILUnited Therapeutics Corporation8ed2003a-c801-411e-831e-d06079bb0d7c2024-11-20Warnings, Adverse reactionsExact identifier
rxcui: 2630668

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8ed2003a-c801-411e-831e-d06079bb0d7c{126 (12 HR treprostinil 0.125 MG Extended Release Oral Tablet) / 210 (12 HR treprostinil 0.25 MG Extended Release Oral Tablet) } Pack [GPCK] · treprostinil Oral Tablet Month 2 Titration Kit [PSN] · treprostinil Oral Tablet Month 2 Titration Kit [SY]324These highlights do not include all the information needed to use ORENITRAM safely and effectively. See Full Prescribing Information for ORENITRAM. ORENITRAM ® (treprostinil) extended-release tablets, for oral use Initial U.S. Approval: 200220241120